SCHEMBL586938

SCHEMBL586938

CCOC(=O)CC(=O)[C@@H]1CCN(C(=O)OC)[C@H](CCc2ccc(F)cc2)C1.COC(=O)N1CCC(C(=O)O)CC1CCc1ccc(F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.37
CACNA1G O43497 2/20 0.36
HTR2A P28223 3/20 0.36
GRM2 Q14416 2/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
RECQL P46063 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
OPRM1 P35372 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
CHRM1 P11229 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTR2C P28335 1/20 0.34
HTR7 P34969 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL586937 1.00 FFAR4 (0.37) FFAR4CACNA1GHTR2AGRM2ALDH1A1
SCHEMBL581333 0.96 CACNA1G (0.38) CACNA1GHTR2AGRM2ALDH1A1KDM4E
SCHEMBL3085356 0.96 CACNA1G (0.38) CACNA1GHTR2AGRM2ALDH1A1KDM4E
SCHEMBL581334 0.96 CACNA1G (0.38) CACNA1GHTR2AGRM2ALDH1A1KDM4E
SCHEMBL582130 0.89 FFAR4 (0.43) FFAR4CACNA1GHTR2AGRM2ALDH1A1
SCHEMBL581685 0.89 PKM (0.42) ALDH1A1KDM4ENPC1MAPTMEN1
SCHEMBL3080016 0.89 PKM (0.42) ALDH1A1KDM4ENPC1MAPTMEN1
SCHEMBL3073261 0.89 PKM (0.42) ALDH1A1KDM4ENPC1MAPTMEN1
SCHEMBL582086 0.87 PPARG (0.40) ALDH1A1KDM4ENPC1GAAMAPT
SCHEMBL3075222 0.87 PPARG (0.40) ALDH1A1KDM4ENPC1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2417131-A1 ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS AstraZeneca AB (SE) 2012-02-15 EP disclosed
WO-2010117323-A1 METHOD AND APPARATUS FOR PRODUCING HEAT ENERGY AND CARBON DIOXIDE ASTRAZENECA AB (SE) 2010-10-14 WO disclosed